Search – Page 50 – Indianapolis Business Journal

Home » Search

Articles

UPDATE: Lilly stock down 9% after results from drug for Alzheimer’s falls short of hopes

March 15, 2021 | John Russell

Caregivers around the world are eager to find a treatment for Alzheimer’s disease, and any sign that a drugmaker is getting closer sparks interest on Wall Street.

Lilly’s Alzheimer’s drug shows modest benefit in mid-stage trial

March 13, 2021 | Bloomberg News

Eli Lilly and Co. on Saturday morning presented highly anticipated details from a mid-stage study showing that its experimental drug slowed Alzheimer’s disease progression over about 18 months.

Lilly stock poised for record if Alzheimer’s drug results shine

March 12, 2021 | Bloomberg News

Indianapolis-based Eli Lilly and Co. is set to report results from a trial of its experimental Alzheimer’s medicine on Saturday in a move that could boost shares of the year’s already best-performing big drugmaker.

Insider alleges Lilly blocked her efforts to sound alarms about U.S. drug factory

March 11, 2021 | Marisa Taylor and Dan Levine, Reuters

Eli Lilly and Co. told Reuters news agency that it is working closely with the FDA to address concerns about the factory in Branchburg, New Jersey, which makes Trulicity.

Lilly Endowment approves another $16.75M in grants for pandemic needs in Indiana

March 8, 2021 | IBJ Staff

The funds will be used for housing, food and child care assistance, among other needs determined by local communities.

State seeks to regulate pharmacy benefit managers

February 26, 2021 | John Russell

Three bills advancing through the Indiana General Assembly would provide tighter regulation of pharmacy benefits managers (PBMs).

Lilly signs deal to sell $210M worth of COVID-19 antibodies to U.S. government

February 26, 2021 | John Russell

The Indianapolis-based drugmaker said it will begin shipping the additional doses immediately to the federal government, which controls distribution of the drugs.

Cultural Trail secures $1M donation for expansion project

February 23, 2021 | Susan Orr

The donation, from the Eli Lilly and Co. Foundation, brings the project’s fundraising total to $27 million. The total project cost is estimated at $30 million.

Downtown office market set to shift as firms rethink space

February 19, 2021 | Mickey Shuey

A Salesforce decision to permit employees to work remotely even once the pandemic subsides could have long-lasting effects on the downtown office market.

Entrepreneurship activity in Indiana is sluggish, Brookings report finds

February 19, 2021 | Susan Orr

As a result, the report argues, the state is not as well-positioned as it might be to rebound from economic downturns.

K.L. Allen: Let’s solve workforce inequities heightened by virus

February 17, 2021 | K.L. Allen

Prioritizing access to education and workforce development opportunities is one important and necessary step in the right direction toward a more equitable workforce.

Indiana Senate panel advances bill that would pass along drug rebates to consumers

February 17, 2021 | John Russell

The bill pitted the two largest companies headquartered in Indianapolis—drugmaker Eli Lilly and Co. and health insurer Anthem Inc.—on opposite sides of the issue.

Indiana factories losing ground as Biden readies manufacturing push

February 16, 2021 | The Washington Post

Productivity in Indiana’s most advanced industries—including agricultural chemicals, medical equipment and adhesives production—has lagged behind the national average for the past 10 years and the gap is widening, according to a new Brookings Institution study.

Lawmakers kill bill that would have stripped control of IMPD away from city

February 16, 2021 | Lindsey Erdody

The Senate Corrections and Criminal Law Committee on Tuesday amended Senate Bill 168, which would have created a five-member board to oversee and govern the Indianapolis police department, to recommend the issue be discussed in a summer study committee.

IBJ Podcast: Why business execs are pushing back against legislative interference in Indy

February 15, 2021 | IBJ Staff

More than 60 business and not-for-profit executives have signed a letter telling lawmakers to back off proposals that would restrict or usurp power from city government in Indianapolis.

Editorial: Business community is right to rise up against legislative interference in Indy

February 12, 2021

We believe in local control. We expect Republicans to believe in local control, too. And so it’s baffling to us that some of the General Assembly’s most conservative lawmakers are leading the efforts to interfere in the way Indianapolis officials govern their city.

Letter: Lawmakers should back off heavy-handed limits on locals

February 11, 2021

A recent pattern of legislative proposals attacks local control in ways that would slow our economic recovery and risk long-term progress on public safety.

More than 60 execs sign letter urging lawmakers to resist ‘heavy-handed limits’ on Indianapolis government

February 11, 2021 | Lindsey Erdody

The letter—signed by leaders at Eli Lilly and Co., Elanco, OneAmerica, Anthem Inc., IU Health, Salesforce and Roche Diagnostics, among others—acknowledges that the city faces economic, housing and crime problems, but the executives say they believe local officials are the ones best equipped to tackle those challenges.

Former Lilly CFO Smiley to lose millions of dollars under separation agreement

February 10, 2021 | John Russell

Josh Smiley, Lilly’s CFO since 2018, resigned from the company after the drugmaker said he had engaged in a improper personal relationship with an employee.

« Previous 1 … 48 49 50 51 52 … 221 Next »

Search Results

4,410 results for '\"eli lilly\"'